Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study

In recent years, a wide range of clinical infections are being caused by carbapenem-resistant Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa. This is a matter of great concern, as carbapenem-resistant infections have fewer treatment options. The Enterobacterales comprises a lar...

Full description

Bibliographic Details
Main Authors:	Gaurav Verma, Subham Ravi Nayak, Swetapadma Jena, Subhra Snigdha Panda, Dipti Pattnaik, A.K. Praharaj, Nipa Singh
Format:	Article
Language:	English
Published:	Journal of Pure and Applied Microbiology 2023-12-01
Series:	Journal of Pure and Applied Microbiology
Subjects:	carbapenem resistant enterobacterales pseudomonas aeruginosa acinetobacter baumannii
Online Access:	https://microbiologyjournal.org/prevalence-of-carbapenem-resistant-enterobacterales-acinetobacter-baumannii-and-pseudomonas-aeruginosa-in-a-tertiary-care-hospital-in-eastern-india-a-pilot-study/

Similar Items

Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales in Fiji: a multicentre prospective observational studyResearch in context
by: Sakiusa C. Baleivanualala, et al.
Published: (2024-06-01)

Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration Indicações da evolução da resistência ao carbapenem através da heteroresistência como estágio intermediário no Acinetobacter baumannii após administração de carbapenem
by: Silvana Vargas Superti, et al.
Published: (2009-04-01)

Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures
by: Shuk-Ching Wong, et al.
Published: (2022-08-01)

Carbapenem Resistant Acinetobacter baumannii: Current Status of Problem in a Tertiary Care Hospital, Jaipur
by: Ekadashi Rajni, et al.
Published: (2023-06-01)

Carbapenem-resistant Acinetobacter baumannii carrier detection: a simple and efficient protocol
by: Jonathan Lellouche, et al.
Published: (2024-04-01)

Hemorrhagic bronchitis caused by carbapenem-resistant Acinetobacter baumannii infection: A case report
by: Zifang Li, et al.
Published: (2024-01-01)

Antimicrobial Susceptibility Pattern of Acinetobacter Baumannii and Rate of Carbapenem Resistance at a Tertiary Care Hospital in Karachi
by: Shomaila Malik, et al.
Published: (2017-06-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Li L, et al.
Published: (2024-12-01)

Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
by: Du N, et al.
Published: (2024-08-01)

Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
by: Xingchen Bian, et al.
Published: (2024-12-01)

Characterisation of pellicle-forming ability in clinical carbapenem-resistant Acinetobacter baumannii
by: Heng Kang Ng, et al.
Published: (2023-05-01)

World Health Organization priority antimicrobial resistance in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecium healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational studyResearch in context
by: Laura C. Antochevis, et al.
Published: (2025-03-01)

Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
by: Suyeon Park, et al.
Published: (2025-02-01)

Four genotypes of carbapenem-resistant Acinetobacter baumannii strains lacking OXA-23 production in Korea
by: Young Ah Kim, et al.
Published: (2024-06-01)

In Silico Exploring of the Antibiotic Adjuvant Potential of some Natural Ligands in Carbapenem-Resistance Acinetobacter baumannii
by: Elaheh Zadeh Hosseingholi, et al.
Published: (2024-02-01)

Cefiderocol in Combating Carbapenem-Resistant <i>Acinetobacter baumannii</i>: Action and Resistance
by: Bahman Yousefi, et al.
Published: (2024-11-01)

Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
by: Yu-Chia Hsieh, et al.
Published: (2020-01-01)

A global view on carbapenem-resistant Acinetobacter baumannii
by: Carina Müller, et al.
Published: (2023-12-01)

Antimicrobial resistance of multidrug-resistant Enterobacterales and Acinetobacter baumannii isolates to colistin in a Moroccan hospital
by: Nadia El mrimar, et al.
Published: (2024-08-01)

In-silico study of Lebanese herbal compounds against carbapenem-resistant Acinetobacter baumannii proteins
by: Israa Assaf, et al.
Published: (2023-01-01)

Genomic Analysis of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolated from Bloodstream Infections in South Korea
by: Wook Jong Jeon, et al.
Published: (2024-11-01)

Clinical and molecular predictors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: A retrospective cohort study
by: Jin Woong Suh, et al.
Published: (2024-02-01)

Carbapenem-resistant Acinetobacter baumannii (CRAB): metabolic adaptation and transcriptional response to human urine (HU)
by: Jenny Escalante, et al.
Published: (2024-08-01)

Anti-biofilm Activity of Phage ΦKAB and Colistin Against Carbapenem Resistance Acinetobacter baumannii
by: Kareema Ali Bahr, et al.
Published: (2024-06-01)

EFFICACY OF COLISTIN AND CEFIDEROCOL ON CARBAPENEM RESISTANT Acinetobacter baumannii ISOLATES
by: Feyza Balci, et al.
Published: (2024-12-01)

Identifying risk factors for carbapenem-resistant Acinetobacter baumannii carriage upon admission: a case-case control study
by: Debby Ben-David, et al.
Published: (2024-12-01)

Ineffectiveness of colistin monotherapy in treating carbapenem-resistant Acinetobacter baumannii Pneumonia: A retrospective single-center cohort study
by: Cheon-Hoo Jeon, et al.
Published: (2024-05-01)

Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022
by: Mark G. Wise, et al.
Published: (2024-06-01)

The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii
by: Fanny Huang, et al.
Published: (2020-08-01)

Carbapenem-resistant Acinetobacter baumannii and Ventilator-associated Pneumonia; Epidemiology, Risk Factors, and Current Therapeutic Approaches
by: Malihe Kazemi Najafabadi, et al.
Published: (2024-04-01)

Investigation on a suspected outbreak of carbapenem-resistant Acinetobacter baumannii nosocomial infection in an intensive care unit
by: HUANG Mei, et al.
Published: (2024-05-01)

Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Yoon-Jung Choi, et al.
Published: (2024-06-01)

Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis
by: Yangyang Zhan, et al.
Published: (2024-09-01)

Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children
by: Yufei Zhang, et al.
Published: (2023-11-01)

Nosocomial carbapenem-drug resistant Acinetobacter baumannii, related factors and clinical outcomes in Northeast Iran
by: Yasaman Alidoosti, et al.
Published: (2024-10-01)

Emergence of eravacycline heteroresistance in carbapenem-resistant Acinetobacter baumannii isolates in China
by: Yi-tan Li, et al.
Published: (2024-03-01)

Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
by: Montserrat Rodríguez-Aguirregabiria, et al.
Published: (2024-08-01)

Active surveillance for carbapenem-resistant Acinetobacter baumannii (CRAB) carriage
by: Amir Nutman, et al.
Published: (2023-12-01)

Genotypes and β-Lactamase Gene Carriage in Carbapenem-Resistant Acinetobacter Baumannii Isolated in Moscow
by: I. V. Chebotar, et al.
Published: (2020-05-01)